Journal article · 2026 · Open access

Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors

Kishan B. Patel, Ishola Abeeb Akinwumi, Tess M. Weber, Monica R. MacDonald, Stephen J. Collins, Surbhi P. Chitnis, Colton L. Zack, Blessing C. Ogboo, Nader N. Nasief, Emily A. Ouellette, Omobolanle A. Abidakun, Michael J. Eck and 5 more

Journal of Medicinal Chemistry, 69(20), 24838–24861 · Published 9 October 2026 · DOI 10.1021/acs.jmedchem.6c02714

Open full textCite this paper

In brief

“Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors” is a 2026 journal article by Kishan B. Patel and 16 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Medicinal Chemistry.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
1.58
References
54
Authors
17

Abstract

Linking small molecules that bind adjacent sites on a target is a promising strategy for developing compounds with tight binding affinities. ATP-allosteric bivalent inhibitors (AABIs) of the epidermal growth factor receptor (EGFR) have provided new insights into efficient linker design where large potency gains can be achieved through particular design scenarios. In this work, we systematically evaluated the structure-activity relationships of target molecules to better understand the most effective approach to maximizing potency through linker optimization. Our results show that linker length and points of connection are both important strategies for significant potency enhancements. Structures and simulations indicate that maximal flexibility is likely the most important design criterion for linking molecules that occupy adjacent pockets, as modeled by the EGFR kinase domain. These studies provide a general framework for the rational design of linkers broadly relevant to fragment-based drug discovery and a number of related scenarios in medicinal chemistry.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Patel, K. B., Akinwumi, I. A., Weber, T. M., MacDonald, M. R., Collins, S. J., Chitnis, S. P., Zack, C. L., Ogboo, B. C., Nasief, N. N., Ouellette, E. A., Abidakun, O. A., Eck, M. J., Brandt, A. L., Wittlinger, F., Laufer, S., Nguyen, H. T., & Heppner, D. E. (2026). Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors. Journal of Medicinal Chemistry, 69(20), 24838–24861. https://doi.org/10.1021/acs.jmedchem.6c02714

MLA 9

Patel, Kishan B., et al. “Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors.” Journal of Medicinal Chemistry, vol. 69, no. 20, 2026, pp. 24838–24861. https://doi.org/10.1021/acs.jmedchem.6c02714.

Chicago

Patel, Kishan B., Ishola Abeeb Akinwumi, Tess M. Weber, Monica R. MacDonald, Stephen J. Collins, Surbhi P. Chitnis, Colton L. Zack, et al. 2026. “Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors.” Journal of Medicinal Chemistry 69 (20): 24838–24861. https://doi.org/10.1021/acs.jmedchem.6c02714.

Harvard

Patel, K. B. et al. (2026) ‘Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors’, Journal of Medicinal Chemistry, 69(20), pp. 24838–24861. doi:10.1021/acs.jmedchem.6c02714.

IEEE

K. B. Patel et al., “Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors,” Journal of Medicinal Chemistry, vol. 69, no. 20, pp. 24838–24861, 2026, doi: 10.1021/acs.jmedchem.6c02714.

BibTeX

@article{patel2026deciphering,
  title     = {{Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors}},
  author    = {Patel, Kishan B. and Akinwumi, Ishola Abeeb and Weber, Tess M. and MacDonald, Monica R. and Collins, Stephen J. and Chitnis, Surbhi P. and Zack, Colton L. and Ogboo, Blessing C. and Nasief, Nader N. and Ouellette, Emily A. and Abidakun, Omobolanle A. and Eck, Michael J. and Brandt, Asher L. and Wittlinger, Florian and Laufer, Stefan and Nguyen, Hung Tan and Heppner, David E.},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  volume    = {69},
  number    = {20},
  pages     = {24838--24861},
  doi       = {10.1021/acs.jmedchem.6c02714},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c02714}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • bivalent inhibitors
  • EGFR
  • structure-activity relationship
  • linker design
  • linker length
  • fragment-based drug discovery
  • kinase domain
  • molecular flexibility

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Patel, K. B., Akinwumi, I. A., Weber, T. M., MacDonald, M. R., Collins, S. J., Chitnis, S. P., Zack, C. L., Ogboo, B. C., Nasief, N. N., Ouellette, E. A., Abidakun, O. A., Eck, M. J., Brandt, A. L., Wittlinger, F., Laufer, S., Nguyen, H. T., & Heppner, D. E. (2026). Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors. Journal of Medicinal Chemistry, 69(20), 24838–24861. https://doi.org/10.1021/acs.jmedchem.6c02714

How many times has this paper been cited?

1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Medicinal Chemistry: sign in and open the full text from this page.

Who wrote this paper?

Kishan B. Patel, Ishola Abeeb Akinwumi, Tess M. Weber, Monica R. MacDonald, Stephen J. Collins, Surbhi P. Chitnis, Colton L. Zack, Blessing C. Ogboo, Nader N. Nasief, Emily A. Ouellette, Omobolanle A. Abidakun, Michael J. Eck and 5 more.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c02714, permanently at https://doi.org/10.1021/acs.jmedchem.6c02714. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.